3U86 - JenaLib

Asymmetric/Biological Unit (100, 100)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_005425	P	12	L	MEN1_HUMAN	Disease (MEN1)	794728614	A	P	12	L
002	UniProt	VAR_005426	L	22	R	MEN1_HUMAN	Disease (MEN1)	104894256	A	L	22	R
003	UniProt	VAR_005427	E	26	K	MEN1_HUMAN	Disease (MEN1)	28931612	A	E	26	K
004	UniProt	VAR_005428	L	39	W	MEN1_HUMAN	Disease (MEN1)	---	A	L	39	W
005	UniProt	VAR_005429	G	42	D	MEN1_HUMAN	Disease (MEN1)	---	A	G	42	D
006	UniProt	VAR_005430	E	45	G	MEN1_HUMAN	Disease (MEN1)	---	A	E	45	G
007	UniProt	VAR_039587	E	45	K	MEN1_HUMAN	Disease (MEN1)	---	A	E	45	K
008	UniProt	VAR_039588	R	98	L	MEN1_HUMAN	Disease (MEN1)	---	A	R	98	L
009	UniProt	VAR_039589	G	110	E	MEN1_HUMAN	Disease (MEN1)	---	A	G	110	E
010	UniProt	VAR_005434	K	135	I	MEN1_HUMAN	Disease (MEN1)	---	A	K	135	I
011	UniProt	VAR_005432	H	139	D	MEN1_HUMAN	Disease (MEN1)	104894263	A	H	139	D
012	UniProt	VAR_039590	H	139	P	MEN1_HUMAN	Disease (MEN1)	---	A	H	139	P
013	UniProt	VAR_039591	H	139	R	MEN1_HUMAN	Disease (MEN1)	---	A	H	139	R
014	UniProt	VAR_005433	H	139	Y	MEN1_HUMAN	Disease (MEN1)	---	A	H	139	Y
015	UniProt	VAR_005436	F	144	V	MEN1_HUMAN	Disease (MEN1)	---	A	F	144	V
016	UniProt	VAR_065153	I	147	F	MEN1_HUMAN	Disease (MEN1)	---	A	I	147	F
017	UniProt	VAR_065154	L	157	W	MEN1_HUMAN	Unclassified	---	A	L	152	W
018	UniProt	VAR_039592	D	158	V	MEN1_HUMAN	Disease (MEN1)	---	A	D	153	V
019	UniProt	VAR_039593	S	159	I	MEN1_HUMAN	Disease (MEN1)	---	A	S	154	I
020	UniProt	VAR_039594	S	160	F	MEN1_HUMAN	Disease (MEN1)	---	A	S	155	F
021	UniProt	VAR_008017	G	161	D	MEN1_HUMAN	Unclassified	---	A	G	156	D
022	UniProt	VAR_005437	A	165	P	MEN1_HUMAN	Disease (MEN1)	---	A	A	160	P
023	UniProt	VAR_039595	A	165	T	MEN1_HUMAN	Disease (MEN1)	---	A	A	160	T
024	UniProt	VAR_039596	V	167	F	MEN1_HUMAN	Disease (MEN1)	---	A	V	162	F
025	UniProt	VAR_005438	A	169	D	MEN1_HUMAN	Disease (MEN1)	---	A	A	164	D
026	UniProt	VAR_039597	C	170	R	MEN1_HUMAN	Disease (MEN1)	---	A	C	165	R
027	UniProt	VAR_039598	L	173	P	MEN1_HUMAN	Disease (MEN1)	386134256	A	L	168	P
028	UniProt	VAR_005440	R	176	Q	MEN1_HUMAN	Polymorphism	607969	A	R	171	Q
029	UniProt	VAR_005441	D	177	Y	MEN1_HUMAN	Disease (MEN1)	---	A	D	172	Y
030	UniProt	VAR_005442	A	181	P	MEN1_HUMAN	Disease (MEN1)	376872829	A	A	176	P
031	UniProt	VAR_005443	E	184	D	MEN1_HUMAN	Disease (MEN1)	---	A	E	179	D
032	UniProt	VAR_039599	E	184	K	MEN1_HUMAN	Disease (MEN1)	---	A	E	179	K
033	UniProt	VAR_039600	E	184	Q	MEN1_HUMAN	Disease (MEN1)	---	A	E	179	Q
034	UniProt	VAR_039601	H	186	R	MEN1_HUMAN	Disease (MEN1)	---	A	H	181	R
035	UniProt	VAR_039602	W	188	R	MEN1_HUMAN	Unclassified	794728649	A	W	183	R
036	UniProt	VAR_005444	W	188	S	MEN1_HUMAN	Disease (MEN1)	---	A	W	183	S
037	UniProt	VAR_005445	V	189	E	MEN1_HUMAN	Disease	104894262	A	V	184	E
038	UniProt	VAR_064937	V	220	F	MEN1_HUMAN	Unclassified	---	A	V	215	F
039	UniProt	VAR_039603	V	220	M	MEN1_HUMAN	Disease (MEN1)	794728621	A	V	215	M
040	UniProt	VAR_005446	L	228	P	MEN1_HUMAN	Disease (MEN1)	---	A	L	223	P
041	UniProt	VAR_039604	G	230	R	MEN1_HUMAN	Disease (MEN1)	---	A	G	225	R
042	UniProt	VAR_039605	R	234	L	MEN1_HUMAN	Disease (MEN1)	---	A	R	229	L
043	UniProt	VAR_039606	V	245	F	MEN1_HUMAN	Disease (MEN1)	---	A	V	240	F
044	UniProt	VAR_039607	C	246	F	MEN1_HUMAN	Disease (MEN1)	---	A	C	241	F
045	UniProt	VAR_008018	C	246	R	MEN1_HUMAN	Disease (MEN1)	---	A	C	241	R
046	UniProt	VAR_039608	C	246	Y	MEN1_HUMAN	Disease (MEN1)	794728624	A	C	241	Y
047	UniProt	VAR_005447	A	247	V	MEN1_HUMAN	Disease (MEN1)	---	A	A	242	V
048	UniProt	VAR_039609	S	258	P	MEN1_HUMAN	Disease (MEN1)	---	A	S	253	P
049	UniProt	VAR_039610	S	258	W	MEN1_HUMAN	Unclassified	---	A	S	253	W
050	UniProt	VAR_005448	E	260	K	MEN1_HUMAN	Disease	104894268	A	E	255	K
051	UniProt	VAR_039611	L	264	R	MEN1_HUMAN	Disease (MEN1)	---	A	L	259	R
052	UniProt	VAR_039612	Q	265	P	MEN1_HUMAN	Disease	---	A	Q	260	P
053	UniProt	VAR_005449	L	269	P	MEN1_HUMAN	Disease (MEN1)	---	A	L	264	P
054	UniProt	VAR_005450	L	272	P	MEN1_HUMAN	Disease	---	A	L	267	P
055	UniProt	VAR_039614	E	279	A	MEN1_HUMAN	Unclassified	---	A	E	274	A
056	UniProt	VAR_039615	P	282	H	MEN1_HUMAN	Disease	---	A	P	277	H
057	UniProt	VAR_039616	G	286	R	MEN1_HUMAN	Disease (MEN1)	---	A	G	281	R
058	UniProt	VAR_005451	A	289	E	MEN1_HUMAN	Disease (MEN1)	---	A	A	284	E
059	UniProt	VAR_039617	A	289	P	MEN1_HUMAN	Unclassified	---	A	A	284	P
060	UniProt	VAR_005452	L	291	P	MEN1_HUMAN	Disease (MEN1)	---	A	L	286	P
061	UniProt	VAR_039618	G	310	D	MEN1_HUMAN	Disease	---	A	G	305	D
062	UniProt	VAR_005453	A	314	P	MEN1_HUMAN	Disease (MEN1)	---	A	A	309	P
063	UniProt	VAR_039619	T	316	P	MEN1_HUMAN	Disease (MEN1)	---	A	T	311	P
064	UniProt	VAR_005454	R	319	P	MEN1_HUMAN	Disease (MEN1)	---	A	R	314	P
065	UniProt	VAR_039620	H	322	R	MEN1_HUMAN	Disease (MEN1)	---	A	H	317	R
066	UniProt	VAR_039621	H	322	Y	MEN1_HUMAN	Disease (MEN1)	---	A	H	317	Y
067	UniProt	VAR_039622	P	325	L	MEN1_HUMAN	Disease (MEN1)	---	A	P	320	L
068	UniProt	VAR_039623	P	325	R	MEN1_HUMAN	Disease (MEN1)	---	A	P	320	R
069	UniProt	VAR_039624	A	330	P	MEN1_HUMAN	Disease (MEN1)	---	A	A	325	P
070	UniProt	VAR_005455	A	342	D	MEN1_HUMAN	Disease (MEN1)	2071312	A	A	337	D
071	UniProt	VAR_039625	A	342	P	MEN1_HUMAN	Disease (MEN1)	---	A	A	337	P
072	UniProt	VAR_005456	W	346	R	MEN1_HUMAN	Disease (MEN1)	---	A	W	341	R
073	UniProt	VAR_039626	A	347	P	MEN1_HUMAN	Disease (MEN1)	---	A	A	342	P
074	UniProt	VAR_005457	T	349	R	MEN1_HUMAN	Disease (MEN1)	---	A	T	344	R
075	UniProt	VAR_039627	I	353	N	MEN1_HUMAN	Disease (MEN1)	---	A	I	348	N
076	UniProt	VAR_039628	Y	358	D	MEN1_HUMAN	Disease (MEN1)	---	A	Y	353	D
077	UniProt	VAR_039629	R	360	W	MEN1_HUMAN	Disease (MEN1)	---	A	R	355	W
078	UniProt	VAR_039630	D	362	H	MEN1_HUMAN	Disease (MEN1)	---	A	D	357	H
079	UniProt	VAR_005458	E	364	K	MEN1_HUMAN	Disease (MEN1)	387906552	A	E	359	K
080	UniProt	VAR_005460	A	373	D	MEN1_HUMAN	Disease (MEN1)	---	A	A	368	D
081	UniProt	VAR_039631	I	377	M	MEN1_HUMAN	Disease (MEN1)	---	A	I	372	M
082	UniProt	VAR_039632	P	378	S	MEN1_HUMAN	Disease (MEN1)	---	A	P	373	S
083	UniProt	VAR_039633	A	390	V	MEN1_HUMAN	Disease (MEN1)	---	A	A	385	V
084	UniProt	VAR_039634	A	416	P	MEN1_HUMAN	Disease (MEN1)	---	A	A	411	P
085	UniProt	VAR_065155	L	418	R	MEN1_HUMAN	Disease (MEN1)	---	A	L	413	R
086	UniProt	VAR_039635	L	419	P	MEN1_HUMAN	Disease (MEN1)	---	A	L	414	P
087	UniProt	VAR_039636	R	420	P	MEN1_HUMAN	Disease (MEN1)	---	A	R	415	P
088	UniProt	VAR_039637	D	423	H	MEN1_HUMAN	Disease (MEN1)	104894264	A	D	418	H
089	UniProt	VAR_005461	D	423	N	MEN1_HUMAN	Disease (MEN1)	104894264	A	D	418	N
090	UniProt	VAR_039638	C	426	Y	MEN1_HUMAN	Disease (MEN1)	386134249	A	C	421	Y
091	UniProt	VAR_039639	W	428	S	MEN1_HUMAN	Disease (MEN1)	---	A	W	423	S
092	UniProt	VAR_039640	S	432	R	MEN1_HUMAN	Disease (MEN1)	---	A	S	427	R
093	UniProt	VAR_039641	W	441	C	MEN1_HUMAN	Disease (MEN1)	398124435	A	W	436	C
094	UniProt	VAR_005464	W	441	R	MEN1_HUMAN	Disease (MEN1)	104894259	A	W	436	R
095	UniProt	VAR_039642	L	449	P	MEN1_HUMAN	Disease (MEN1)	---	A	L	444	P
096	UniProt	VAR_005465	F	452	S	MEN1_HUMAN	Disease (MEN1)	---	A	F	447	S
097	UniProt	VAR_039643	R	532	C	MEN1_HUMAN	Disease (MEN1)	---	A	R	527	C
098	UniProt	VAR_039646	T	557	S	MEN1_HUMAN	Polymorphism	121913035	A	T	552	S
099	UniProt	VAR_005467	S	560	N	MEN1_HUMAN	Disease (MEN1)	863224527	A	S	555	N
100	UniProt	VAR_039647	S	560	R	MEN1_HUMAN	Disease (MEN1)	---	A	S	555	R

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (0, 0)

Exons (0, 0)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:484
 aligned with MEN1_HUMAN | O00255 from UniProtKB/Swiss-Prot  Length:615

    Alignment length:585
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551       561       571       581     
           MEN1_HUMAN     2 GLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGWSPVGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSREAEAAEAEEPWGEEAREGRRRGPRRESKPEEPPPPKKPALDKGLGTGQGAVSGPPRKPPGTVAGTARGPEGGSTAQVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTA 586
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..hhhhhh.....hhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhh............eeeee.......eeeee..hhhhhhhhhhhhhhhhhhhh............hhhhhhhhhhhhhhh.............hhhhhhh-----h...hhhhhhhhhhhhhhhh.....eeee....eeeee.....eee................hhhhhhh....hhhhh.ee.hhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhh.hhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhh.....----------------....hhhhhhhhhhhhhhhhhhhh.......hhhhhhhhhhhhh..hhhhhh..ee..------------------------------------------------------------........--------------------..ee...hhhhhhhhhhhh....hhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) ----------L---------R---K------------W--D--G----------------------------------------------------L-----------E------------------------I---D----V--F---------WVIFD---P-F-DR--P--QY---P--D-R-RE------------------------------F-------P-R---L----------FFV----------P-K---RP---P--P------A--H---R--E-P------------------D---P-P--P--R--L----P-----------D---RP-R---N----D-W-H-K--------D---MS-----------V-------------------------P-RPP--H--Y-S---R--------C-------P--S-------------------------------------------------------------------------------C------------------------S--N-------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------K---------------------------------------------------------------------------------------------P-------------------------T------------------K---S-------------------------------M-------------------------R-----------W------------------------------P--------------------------------Y--R----------------P--------------------------------------------------------------------------------N-----------------R----------------------------------------------------------------------------------------------------------------------R-------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------------------------------------------------------------------------------------------------------------------------R--------------------------------------------Q-------------------------------------------------------------Y---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------------------------------------------------------------------------------------------------------------------------Y--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (4)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3u86 A   2 GLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFIT-----GTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEA----------------SALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVS------------------------------------------------------------GTVAGTAR--------------------GPVLTFQSEKMKGMKELLVATKINSSAIKLQLTA 581
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141      |  -  |    156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376        |-         -     | 406       416       426       436       446       456  |      -         -         -         -         -         -   |   526|        -         - |     556       566       576     
                                                                                                                                                                            148   149                                                                                                                                                                                                                                         385              402                                                      459                                                          520    527                  548

Chain B from PDB  Type:PROTEIN  Length:12
 aligned with JUND_HUMAN | P17535 from UniProtKB/Swiss-Prot  Length:347

    Alignment length:18
                                    39        
           JUND_HUMAN    30 RLFPGAPPTAAAGSMMKK  47
               SCOP domains ------------------ SCOP domains
               CATH domains ------------------ CATH domains
               Pfam domains ------------------ Pfam domains
         Sec.struct. author ..........------.. Sec.struct. author
                 SAPs(SNPs) ------------------ SAPs(SNPs)
                    PROSITE ------------------ PROSITE
                 Transcript ------------------ Transcript
                 3u86 B  30 RLFPGAPPTA------KK  47
                                    39      | 
                                    39     46

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (87, 100)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (MEN1_HUMAN | O00255)

molecular function
	GO:0003677	DNA binding	Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
	GO:0070412	R-SMAD binding	Interacting selectively and non-covalently with a receptor-regulated SMAD signaling protein.
	GO:0000403	Y-form DNA binding	Interacting selectively and non-covalently with segment of DNA shaped like a Y. This shape occurs when DNA contains a region of paired double-stranded DNA on one end and a region of unpaired DNA strands on the opposite end.
	GO:0003682	chromatin binding	Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
	GO:0003690	double-stranded DNA binding	Interacting selectively and non-covalently with double-stranded DNA.
	GO:0000400	four-way junction DNA binding	Interacting selectively and non-covalently with DNA containing four-way junctions, also known as Holliday junctions, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices.
	GO:0018024	histone-lysine N-methyltransferase activity	Catalysis of the reaction: S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine + histone N6-methyl-L-lysine. The methylation of peptidyl-lysine in histones forms N6-methyl-L-lysine, N6,N6-dimethyl-L-lysine and N6,N6,N6-trimethyl-L-lysine derivatives.
	GO:0047485	protein N-terminus binding	Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0030674	protein binding, bridging	The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
	GO:0044212	transcription regulatory region DNA binding	Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
biological process
	GO:0006281	DNA repair	The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:1904837	beta-catenin-TCF complex assembly	The aggregation, arrangement and bonding together of a set of components to form a beta-catenin-TCF complex.
	GO:0007420	brain development	The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
	GO:0006974	cellular response to DNA damage stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.
	GO:0071333	cellular response to glucose stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
	GO:0071375	cellular response to peptide hormone stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
	GO:0046697	decidualization	The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta.
	GO:0034968	histone lysine methylation	The modification of a histone by addition of one or more methyl groups to a lysine residue.
	GO:0000278	mitotic cell cycle	Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.
	GO:0046329	negative regulation of JNK cascade	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the JNK cascade.
	GO:0045786	negative regulation of cell cycle	Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
	GO:1902807	negative regulation of cell cycle G1/S phase transition	Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle G1/S phase transition.
	GO:0008285	negative regulation of cell proliferation	Any process that stops, prevents or reduces the rate or extent of cell proliferation.
	GO:0010812	negative regulation of cell-substrate adhesion	Any process that decreases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	Any process that stops, prevents, or reduces the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.
	GO:0050680	negative regulation of epithelial cell proliferation	Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
	GO:0045668	negative regulation of osteoblast differentiation	Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
	GO:0001933	negative regulation of protein phosphorylation	Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
	GO:0051974	negative regulation of telomerase activity	Any process that stops or reduces the activity of the enzyme telomerase, which catalyzes of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0045892	negative regulation of transcription, DNA-templated	Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0002076	osteoblast development	The process whose specific outcome is the progression of an osteoblast over time, from its formation to the mature structure. Osteoblast development does not include the steps involved in committing a cranial neural crest cell or an osteoprogenitor cell to an osteoblast fate. An osteoblast is a cell that gives rise to bone.
	GO:0032092	positive regulation of protein binding	Any process that activates or increases the frequency, rate or extent of protein binding.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity.
	GO:0032925	regulation of activin receptor signaling pathway	Any process that modulates the frequency, rate or extent of the activity of any activin receptor signaling pathway.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0061469	regulation of type B pancreatic cell proliferation	Any process that modulates the frequency, rate or extent of type B pancreatic cell proliferation.
	GO:0009411	response to UV	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
	GO:0010332	response to gamma radiation	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
	GO:0071559	response to transforming growth factor beta	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
	GO:0003309	type B pancreatic cell differentiation	The process in which relatively unspecialized cells acquire specialized structural and/or functional features of a type B pancreatic cell. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
cellular component
	GO:0000785	chromatin	The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
	GO:0032154	cleavage furrow	The cleavage furrow is a plasma membrane invagination at the cell division site. The cleavage furrow begins as a shallow groove and eventually deepens to divide the cytoplasm.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0035097	histone methyltransferase complex	A multimeric complex that is able to catalyze the addition of methyl groups to histone proteins.
	GO:0000790	nuclear chromatin	The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
	GO:0000784	nuclear chromosome, telomeric region	The terminal region of a linear nuclear chromosome that includes the telomeric DNA repeats and associated proteins.
	GO:0016363	nuclear matrix	The dense fibrillar network lying on the inner side of the nuclear membrane.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

Chain B (JUND_HUMAN | P17535)

molecular function
	GO:0003677	DNA binding	Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II.
	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0003690	double-stranded DNA binding	Interacting selectively and non-covalently with double-stranded DNA.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0016922	ligand-dependent nuclear receptor binding	Interacting selectively and non-covalently, in a ligand dependent manner, with a nuclear receptor protein.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0043565	sequence-specific DNA binding	Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
	GO:0003713	transcription coactivator activity	Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery.
	GO:0003700	transcription factor activity, sequence-specific DNA binding	Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0008134	transcription factor binding	Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.
	GO:0044212	transcription regulatory region DNA binding	Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
biological process
	GO:0007568	aging	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
	GO:0071277	cellular response to calcium ion	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
	GO:0032870	cellular response to hormone stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
	GO:0007623	circadian rhythm	Any biological process in an organism that recurs with a regularity of approximately 24 hours.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0002076	osteoblast development	The process whose specific outcome is the progression of an osteoblast over time, from its formation to the mature structure. Osteoblast development does not include the steps involved in committing a cranial neural crest cell or an osteoprogenitor cell to an osteoblast fate. An osteoblast is a cell that gives rise to bone.
	GO:0045597	positive regulation of cell differentiation	Any process that activates or increases the frequency, rate or extent of cell differentiation.
	GO:0045669	positive regulation of osteoblast differentiation	Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0051726	regulation of cell cycle	Any process that modulates the rate or extent of progression through the cell cycle.
	GO:0010941	regulation of cell death	Any process that modulates the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
	GO:0042127	regulation of cell proliferation	Any process that modulates the frequency, rate or extent of cell proliferation.
	GO:0006357	regulation of transcription from RNA polymerase II promoter	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0051591	response to cAMP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
	GO:0034097	response to cytokine	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0009416	response to light stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
	GO:0032496	response to lipopolysaccharide	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0009612	response to mechanical stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0014070	response to organic cyclic compound	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0043434	response to peptide hormone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
	GO:0009314	response to radiation	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
	GO:0006366	transcription from RNA polymerase II promoter	The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
cellular component
	GO:0000785	chromatin	The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
	GO:0000790	nuclear chromatin	The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
	GO:0032993	protein-DNA complex	A macromolecular complex containing both protein and DNA molecules.
	GO:0005667	transcription factor complex	A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (0, 0)

Sites (0, 0)

SS Bonds (0, 0)

Cis Peptide Bonds (2, 2)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (100, 100)

PROSITE Motifs (0, 0)

Exons (0, 0)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (87, 100)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File